Skip to main content
Genetics logoLink to Genetics
. 2004 Mar;166(3):1571–1579. doi: 10.1534/genetics.166.3.1571

Stochastic tunnels in evolutionary dynamics.

Yoh Iwasa 1, Franziska Michor 1, Martin A Nowak 1
PMCID: PMC1470783  PMID: 15082570

Abstract

We study a situation that arises in the somatic evolution of cancer. Consider a finite population of replicating cells and a sequence of mutations: type 0 can mutate to type 1, which can mutate to type 2. There is no back mutation. We start with a homogeneous population of type 0. Mutants of type 1 emerge and either become extinct or reach fixation. In both cases, they can generate type 2, which also can become extinct or reach fixation. If mutation rates are small compared to the inverse of the population size, then the stochastic dynamics can be described by transitions between homogeneous populations. A "stochastic tunnel" arises, when the population moves from all 0 to all 2 without ever being all 1. We calculate the exact rate of stochastic tunneling for the case when type 1 is as fit as type 0 or less fit. Type 2 has the highest fitness. We discuss implications for the elimination of tumor suppressor genes and the activation of genetic instability. Although our theory is developed for cancer genetics, stochastic tunnels are general phenomena that could arise in many circumstances.

Full Text

The Full Text of this article is available as a PDF (144.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARMITAGE P., DOLL R. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer. 1957 Jun;11(2):161–169. doi: 10.1038/bjc.1957.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ARMITAGE P., DOLL R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer. 1954 Mar;8(1):1–12. doi: 10.1038/bjc.1954.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bach S. P., Renehan A. G., Potten C. S. Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis. 2000 Mar;21(3):469–476. doi: 10.1093/carcin/21.3.469. [DOI] [PubMed] [Google Scholar]
  4. Bell G. I. Models of carcinogenesis as an escape from mitotic inhibitors. Science. 1976 May 7;192(4239):569–572. doi: 10.1126/science.130679. [DOI] [PubMed] [Google Scholar]
  5. Byrne H. M., Chaplin M. A. Growth of necrotic tumors in the presence and absence of inhibitors. Math Biosci. 1996 Jul 15;135(2):187–216. doi: 10.1016/0025-5564(96)00023-5. [DOI] [PubMed] [Google Scholar]
  6. Cairns John. Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc Natl Acad Sci U S A. 2002 Jul 29;99(16):10567–10570. doi: 10.1073/pnas.162369899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chaplain M. A. The mathematical modelling of tumour angiogenesis and invasion. Acta Biotheor. 1995 Dec;43(4):387–402. doi: 10.1007/BF00713561. [DOI] [PubMed] [Google Scholar]
  8. Cook P. J., Doll R., Fellingham S. A. A mathematical model for the age distribution of cancer in man. Int J Cancer. 1969 Jan 15;4(1):93–112. doi: 10.1002/ijc.2910040113. [DOI] [PubMed] [Google Scholar]
  9. FISHER J. C. Multiple-mutation theory of carcinogenesis. Nature. 1958 Mar 1;181(4609):651–652. doi: 10.1038/181651b0. [DOI] [PubMed] [Google Scholar]
  10. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. doi: 10.1016/0092-8674(90)90186-i. [DOI] [PubMed] [Google Scholar]
  11. Frank Steven A., Iwasa Yoh, Nowak Martin A. Patterns of cell division and the risk of cancer. Genetics. 2003 Apr;163(4):1527–1532. doi: 10.1093/genetics/163.4.1527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gatenby Robert A., Maini Philip K. Mathematical oncology: cancer summed up. Nature. 2003 Jan 23;421(6921):321–321. doi: 10.1038/421321a. [DOI] [PubMed] [Google Scholar]
  13. Goldie J. H., Coldman A. J. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1727–1733. [PubMed] [Google Scholar]
  14. Goldie J. H., Coldman A. J. Genetic instability in the development of drug resistance. Semin Oncol. 1985 Sep;12(3):222–230. [PubMed] [Google Scholar]
  15. Herrero-Jimenez P., Tomita-Mitchell A., Furth E. E., Morgenthaler S., Thilly W. G. Population risk and physiological rate parameters for colon cancer. The union of an explicit model for carcinogenesis with the public health records of the United States. Mutat Res. 2000 Jan 17;447(1):73–116. doi: 10.1016/s0027-5107(99)00201-8. [DOI] [PubMed] [Google Scholar]
  16. Higgs P. G. Compensatory neutral mutations and the evolution of RNA. Genetica. 1998;102-103(1-6):91–101. [PubMed] [Google Scholar]
  17. Innan H., Stephan W. Selection intensity against deleterious mutations in RNA secondary structures and rate of compensatory nucleotide substitutions. Genetics. 2001 Sep;159(1):389–399. doi: 10.1093/genetics/159.1.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Iwasa Yoh, Michor Franziska, Nowak Martin A. Evolutionary dynamics of escape from biomedical intervention. Proc Biol Sci. 2003 Dec 22;270(1533):2573–2578. doi: 10.1098/rspb.2003.2539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Iwasa Yoh, Michor Franziska, Nowak Martin A. Evolutionary dynamics of invasion and escape. J Theor Biol. 2004 Jan 21;226(2):205–214. doi: 10.1016/j.jtbi.2003.08.014. [DOI] [PubMed] [Google Scholar]
  20. Jackson A. L., Loeb L. A. The mutation rate and cancer. Genetics. 1998 Apr;148(4):1483–1490. doi: 10.1093/genetics/148.4.1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Knudson A. G., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Komarova Natalia L., Sengupta Anirvan, Nowak Martin A. Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability. J Theor Biol. 2003 Aug 21;223(4):433–450. doi: 10.1016/s0022-5193(03)00120-6. [DOI] [PubMed] [Google Scholar]
  23. Kovacs L., Potten C. S. An estimation of proliferative population size in stomach, jejunum and colon of DBA-2 mice. Cell Tissue Kinet. 1973 Mar;6(2):125–134. doi: 10.1111/j.1365-2184.1973.tb01601.x. [DOI] [PubMed] [Google Scholar]
  24. Lengauer C., Kinzler K. W., Vogelstein B. Genetic instabilities in human cancers. Nature. 1998 Dec 17;396(6712):643–649. doi: 10.1038/25292. [DOI] [PubMed] [Google Scholar]
  25. Lev Bar-Or R., Maya R., Segel L. A., Alon U., Levine A. J., Oren M. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11250–11255. doi: 10.1073/pnas.210171597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Little M. P., Wright E. G. A stochastic carcinogenesis model incorporating genomic instability fitted to colon cancer data. Math Biosci. 2003 Jun;183(2):111–134. doi: 10.1016/s0025-5564(03)00040-3. [DOI] [PubMed] [Google Scholar]
  27. Loeb L. A. Cancer cells exhibit a mutator phenotype. Adv Cancer Res. 1998;72:25–56. doi: 10.1016/s0065-230x(08)60699-5. [DOI] [PubMed] [Google Scholar]
  28. Loeb L. A., Springgate C. F., Battula N. Errors in DNA replication as a basis of malignant changes. Cancer Res. 1974 Sep;34(9):2311–2321. [PubMed] [Google Scholar]
  29. Michalakis Y., Slatkin M. Interaction of selection and recombination in the fixation of negative-epistatic genes. Genet Res. 1996 Jun;67(3):257–269. doi: 10.1017/s0016672300033747. [DOI] [PubMed] [Google Scholar]
  30. Michor Franziska, Iwasa Yoh, Komarova Natalia L., Nowak Martin A. Local regulation of homeostasis favors chromosomal instability. Curr Biol. 2003 Apr 1;13(7):581–584. doi: 10.1016/s0960-9822(03)00172-6. [DOI] [PubMed] [Google Scholar]
  31. Michor Franziska, Nowak Martin A., Frank Steven A., Iwasa Yoh. Stochastic elimination of cancer cells. Proc Biol Sci. 2003 Oct 7;270(1528):2017–2024. doi: 10.1098/rspb.2003.2483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Moolgavkar S. H., Knudson A. G., Jr Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst. 1981 Jun;66(6):1037–1052. doi: 10.1093/jnci/66.6.1037. [DOI] [PubMed] [Google Scholar]
  33. Nowak Martin A., Komarova Natalia L., Sengupta Anirvan, Jallepalli Prasad V., Shih Ie-Ming, Vogelstein Bert, Lengauer Christoph. The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci U S A. 2002 Nov 21;99(25):16226–16231. doi: 10.1073/pnas.202617399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Phillips P. C. Waiting for a compensatory mutation: phase zero of the shifting-balance process. Genet Res. 1996 Jun;67(3):271–283. doi: 10.1017/s0016672300033759. [DOI] [PubMed] [Google Scholar]
  35. Plotkin Joshua B., Nowak Martin A. The different effects of apoptosis and DNA repair on tumorigenesis. J Theor Biol. 2002 Feb 7;214(3):453–467. doi: 10.1006/jtbi.2001.2471. [DOI] [PubMed] [Google Scholar]
  36. Rajagopalan Harith, Nowak Martin A., Vogelstein Bert, Lengauer Christoph. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer. 2003 Sep;3(9):695–701. doi: 10.1038/nrc1165. [DOI] [PubMed] [Google Scholar]
  37. Savill N. J., Hoyle D. C., Higgs P. G. RNA sequence evolution with secondary structure constraints: comparison of substitution rate models using maximum-likelihood methods. Genetics. 2001 Jan;157(1):399–411. doi: 10.1093/genetics/157.1.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Stephan W. The rate of compensatory evolution. Genetics. 1996 Sep;144(1):419–426. doi: 10.1093/genetics/144.1.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wodarz D., Krakauer D. C. Genetic instability and the evolution of angiogenic tumor cell lines (review). Oncol Rep. 2001 Nov-Dec;8(6):1195–1201. doi: 10.3892/or.8.6.1195. [DOI] [PubMed] [Google Scholar]

Articles from Genetics are provided here courtesy of Oxford University Press

RESOURCES